Infiniplex Ltd

General Data

supplementary funding
Reg Number
516447414
Sector
Biomed
Established
2021
No. of Employees
15
Stage
R&D
Additional Funding
1

Description

Infiniplex is a tech-bio startup developing an inexpensive, reliable, and non-invasive test for cancer screening and treatment effectiveness monitoring.

Technology

Infiniplex is developing advanced liquid biopsy solutions for precision oncology. Its core platform, InfiniplexDX, is designed to enable rapid, sensitive, and accessible mutation detection. By combining proprietary, ultra-high-performance primer design with widely available PCR infrastructure, InfiniplexDX enables rapid, highly sensitive and specific detection of target mutations in blood and urine samples.

Targeted Customers

HMO's, Clinical laboratories, hospitals, oncology centers, healthcare providers, organizations, performing molecular cancer diagnostics and precision-oncology testing.

Management personnel

Alon Shalev - CEO
Zeev Russak - CTO & Co-Founder

Contact information

Name
Ze'ev Russak
Phone
0542396119
Website
https://www.infiniplex.life
Country
Israel
Zip
2066733

Tags

AnalysisBiopsyBiotechnologyCancerDeep TechDetectionGeneticsLife SciencesMedTechTesting

Classified Technologies

Medical Devices
Pharma
Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

R&D Fund
R&D Fund
2024
Technological Incubators
Technological Incubators
2023
Startup Fund
Startup Fund
2025